Adipotide (5mg)

Description

Adipotide 5 mg is a research peptide studied for its unique ability to target and reduce fat tissue by promoting apoptosis in fat-specific blood vessels. Originally known as FTPP (Fat-Targeted Peptide), Adipotide has been the focus of studies exploring fat loss, metabolic health, and obesity-related conditions. Its direct mechanism of action on fat cell vasculature distinguishes it from other peptides commonly studied for weight management.

How It Works
Adipotide works by binding to specific receptors on the blood vessels that supply white adipose tissue (fat). This binding process causes apoptosis (programmed cell death) in the targeted blood vessels, effectively cutting off the nutrient and oxygen supply to fat cells. As a result, fat cells begin to shrink and break down, leading to reduced fat mass in research subjects. Studies have shown promising outcomes in animal models for fat reduction and improved insulin sensitivity.

Key Benefits of Adipotide:

• Directly targets fat cell vasculature for fat reduction
  
• Promotes apoptosis in fat-specific blood vessels
  
• Supports weight loss in research studies
• Improves metabolic health and insulin sensitivity
  
• Aids in the study of obesity-related conditions
• Demonstrates fat reduction without requiring dietary changes in some animal models

Usage and Safety:

• Peptide Name: Adipotide
• Quantity: 5 mg
• Purity: ≥ 99%
  
• Form: Lyophilized powder
  
• Use: For laboratory research only. Not for human consumption.

Adipotide is used in laboratory settings to investigate its impact on fat reduction, weight management, and metabolic health. It is not approved for human or veterinary use.

Disclaimer: This product is for research purposes only and is not intended for human or veterinary use.